Huang G - Search Results

1

[¹⁸F]RCCB6 Immuno-Positron Emission Tomography/Computed Tomography for Postoperative Surveillance in Clear Cell Renal Cell Carcinoma: A Pilot Clinical Study.

Wu Q, Wu Y, Zhang Y, Guan Y, Huang G, Zheng J, Liu J, Xie F, Wei W, Zhai W. Wu Q, et al. Among authors: huang g. Eur Urol. 2024 Oct;86(4):372-374. doi: 10.1016/j.eururo.2024.06.020. Epub 2024 Jul 22. Eur Urol. 2024. PMID: 39043547 No abstract available.

2

Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis.

Zhang C, Chen Y, Xue H, Zheng P, Tong J, Liu J, Sun X, Huang G. Zhang C, et al. Among authors: huang g. Int J Cancer. 2009 Jan 1;124(1):167-73. doi: 10.1002/ijc.23926. Int J Cancer. 2009. PMID: 18844237

3

Comparison of the effect of positive and negative oral contrast agents on (18)F-FDG PET/CT scan.

Sun XG, Huang G, Liu JJ, Wan LR. Sun XG, et al. Among authors: huang g. Hell J Nucl Med. 2009 May-Aug;12(2):115-8. Hell J Nucl Med. 2009. PMID: 19675862 Clinical Trial.

4

Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis.

Tang S, Huang G, Liu J, Liu T, Treven L, Song S, Zhang C, Pan L, Zhang T. Tang S, et al. Among authors: huang g. Eur J Radiol. 2011 Apr;78(1):142-50. doi: 10.1016/j.ejrad.2009.09.026. Epub 2009 Oct 23. Eur J Radiol. 2011. PMID: 19854016

5

18F-FDG PET/CT-related metabolic parameters and their value in early prediction of chemotherapy response in a VX2 tumor model.

Song SL, Deng C, Wen LF, Liu JJ, Wang H, Feng D, Wong CY, Huang G. Song SL, et al. Among authors: huang g. Nucl Med Biol. 2010 Apr;37(3):327-33. doi: 10.1016/j.nucmedbio.2009.12.002. Epub 2010 Jan 15. Nucl Med Biol. 2010. PMID: 20346872

6

Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis.

Wang Y, Zhang C, Liu J, Huang G. Wang Y, et al. Among authors: huang g. Breast Cancer Res Treat. 2012 Jan;131(2):357-69. doi: 10.1007/s10549-011-1780-z. Epub 2011 Sep 30. Breast Cancer Res Treat. 2012. PMID: 21960111

7

Diagnostic value of fecal tumor M2-pyruvate kinase for CRC screening: a systematic review and meta-analysis.

Li R, Liu J, Xue H, Huang G. Li R, et al. Among authors: huang g. Int J Cancer. 2012 Oct 15;131(8):1837-45. doi: 10.1002/ijc.27442. Epub 2012 Mar 8. Int J Cancer. 2012. PMID: 22261915

8

A meta-analysis of interleukin-8 -251 promoter polymorphism associated with gastric cancer risk.

Xue H, Liu J, Lin B, Wang Z, Sun J, Huang G. Xue H, et al. Among authors: huang g. PLoS One. 2012;7(1):e28083. doi: 10.1371/journal.pone.0028083. Epub 2012 Jan 18. PLoS One. 2012. PMID: 22279522 Free PMC article.

9

18F-FDG-PET evaluation of treatment response to neo-adjuvant therapy in patients with locally advanced rectal cancer: a meta-analysis.

Zhang C, Tong J, Sun X, Liu J, Wang Y, Huang G. Zhang C, et al. Among authors: huang g. Int J Cancer. 2012 Dec 1;131(11):2604-11. doi: 10.1002/ijc.27557. Epub 2012 Jun 28. Int J Cancer. 2012. PMID: 22447461 Review.

10

18F-FDG-PET evaluation of pathological tumour response to neoadjuvant therapy in patients with NSCLC.

Zhang C, Liu J, Tong J, Sun X, Song S, Huang G. Zhang C, et al. Among authors: huang g. Nucl Med Commun. 2013 Jan;34(1):71-7. doi: 10.1097/MNM.0b013e3283599999. Nucl Med Commun. 2013. PMID: 23086204

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,329 results

Search Page

Filters